The rise of novel, semi‐synthetic 7‐hydroxymitragynine products

Ähnliche Einträge

• Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?
  von: Gabriela Kattan Khazanov, et al.
  Veröffentlicht: (2024)
• Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis
  von: Jake J. Smith, et al.
  Veröffentlicht: (2025)
• Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well‐documented intoxication cases and basic pharmacological data
  von: Michaela J. Sommer, et al.
  Veröffentlicht: (2025)
• Commentary on Copeland et al.: Does xylazine in the United Kingdom foreshadow a European synthetic polysubstance drug crisis?
  von: Joseph R. Friedman
  Veröffentlicht: (2024)
• Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries
  von: Alexander Soderholm, et al.
  Veröffentlicht: (2024)